Find your path to Lauren
146 people in our graph share verified history with Lauren — schools, employers, funds. One of them is your warm intro.
Robert SoffelunlockedLauren: together at Penn State University (2000–2001)
×5Lauren: together at Penn State University
×3Lauren: together at Code Biotherapeutics
Lauren: together at AAVantgarde Bio
Executive at Code Biotherapeutics
Intro paths
→
In turn, Lauren can intro founders to Code Biotherapeutics's investors below.
Code Biotherapeutics's investors · 8
4BIO CapitalLondon · since 2022Amgen VenturesThousand Oaks · $1M – $3M checks · since 2022Hatteras Venture PartnersResearch Triangle · $500K – $4M checks · since 2022JDRF T1D FundBoston · since 2022New Enterprise Associates (NEA)Menlo Park · $200K – $40M checks · since 2022Northpond VenturesBethesda · $100K – $5M checks · since 2022Takeda VenturesCambridge · $1M – $5M checks · since 2022UCB VenturesBrussels · since 2022
Experience
- LMK ConsultancyFractional C-Level Leadercurrent2025 — present
- Born on a SaturdayFounder, Ownercurrent2025 — present
- AAVantgarde BioChief Business Officer2024 — 2025
- Code BioTherapeuticsChief Business Officer2021 — 2024
- Spark Therapeutics, Inc.Head of Program and Alliance Management, Chief of Staff for Executive Team2019 — 2021Greater Philadelphia Area
- Spark Therapeutics, Inc.Alliance Management Lead ♦ Business Development ♦ Capability Building2015 — 2021Greater Philadelphia Area
Skills & more
OncologyPharmaceutical Industry
Languages English
- Certificate of Achievement - Alliance Management (CA-AM)
From Lauren's professional profile.
Frequently asked questions
- Who is Lauren Kaskiel?
- Executive Officer at Code Biotherapeutics
- Where does Lauren Kaskiel work?
- Lauren Kaskiel is Executive at Code Biotherapeutics.
- Where did Lauren Kaskiel go to school?
- Lauren Kaskiel studied at Drexel University's LeBow College of Business (Master of Business Administration (M.B.A.), Marketing); Penn State University (Bachelor of Science (B.S.), Biotechnology).
Same school
Also attended Drexel University's LeBow College of Business45
Mike PelliniGeneral Partner at S32Alex KatzGeneral Counsel at Ff Venture CapitalUdit DalalVP, Operations at LogosRichelle ParhamObvious Champion at Obvious VenturesShobha VenkataramanPartner at Elevar EquityBrittany GillowDirector, Accounting at Dreamit Ventures
+ 39 more
Also attended Penn State University523
Kelly DonovanExecutive Assistant & Operations Associate, Revolution Growth at RevolutionFallon GoodeExecutive Assistant at March Capital PartnersCristina HohlmanPartner, Chief Financial Officer at Sapphire VenturesNick DolikInvestor at 8VCRobert SoffelRevOps Expert at Notion CapitalLouis BernemanFounding Partner at Osage University Partners
+ 517 more
Shared employers
Also worked at AAVantgarde Bio7
Lucy LiuPrincipal at Longwood FundFederica DraghiFounder and Managing Partner at XGEN VentureDoug KerrScience Advisor at Exceptional VenturesKenneth GriséPrincipal at Sixty Degree CapitalTiziana RossettiPrincipal, Telethon Strategy at Sofinnova PartnersDmitrij HristodorovGeneral Partner at Forbion
+ 1 more
Also worked at Code BioTherapeutics6
Diana BernsteinDirector at Northpond VenturesDima KuzminManaging Partner at 4BIO CapitalBrian McVeighVenture Partner, USA at 4BIO CapitalVic StoneGeneral Partner, President and Head of 82VS Dallas at 82VSKseniya SimpsonPrincipal at Hatteras Venture PartnersKseniya Simpson, PhDPartner at Hatteras Venture Partners
Also worked at Spark Therapeutics, Inc.8
Jason GabrielManaging Director at Syngenta Group VenturesNick OlsenPrincipal at Innovation EndeavorsEgen AtkinsonManaging Partner at Commodore CapitalJeff MarrazzoFounder at Dispatch BiotherapeuticsSteve AltschulerExecutive Chair at Port TherapeuticsKatherine HighCEO at RhyGaze AG
+ 2 more